Skip to content

Mega-Trend Alert: Personalization Is Exploding onto the Scene

Chris Wood Chris Wood | May 13, 2019


Mega-Trend Alert: Personalization Is Exploding onto the Scene

Which Gatorade do you need?

The sports drink manufacturer will introduce its new Gx line of products this year, which it calls a “customizable hydration system.”

For a few years now, Gatorade has also provided customized drinks to top athletes it sponsors by analyzing their rate and type of perspiration. Now amateur athletes can get the same results via a newly developed “sweat patch.”

Personalization is a huge trend, and it’s penetrating every consumer market segment there is.

We’re now seeing personalized hair color by brands like Madison Reed, which combines salon-quality, “multi-tonal” results with color-at-home convenience. All you do is take a quiz to find out which hair color would perfectly match your hair type and dream shade.

Or take Stitch Fix, a clothes shopping concierge service for women, men, and kids.

The homepage declares, “A great wardrobe starts with your perfect fit. Our Stylists discover clothing for you, hand-selected for your unique size & style.”

Your personal styling begins with an in-depth quiz to find out your body type, preferences, and fashion style.

When you sign up with Stitch Fix, you’ll get a package with tops, bottoms, shoes, and accessories every month. You keep what you like and return what you don’t like. It’s that easy.

The unstoppable personalization trend has also been making its way into the healthcare field.

     
-
Bill White

Will the world drown in debt?

See what Bill White thinks—LIVE with your SIC Virtual Pass!

-
     


Precision Care Is Conquering Healthcare

The central point of “Precision Care” is that it seeks to move away from the one-size-fits-all approach that has defined medicine for hundreds of years and make it more personalized.

For example, if you’re willing to answer about 30 questions about your health history, Persona Nutrition offers personalized vitamins, minerals, and other natural compounds tailor-made for you.

After you take the quiz, Persona’s recommendation “is created by our Medical Advisory Board and team of nutritionists.” When you order, the one-month supply is being delivered in handy daily dosages so you don’t even have to think about which pills to take when.

If you’re interested in trying it, by the way, Persona is currently offering a discount deal for Health & Wealth Research readers, giving you 30% off on your first two orders.

My co-editor, Dr. Mike Roizen, is on the board of directors and brokered this deal for us. I myself have been taking Persona supplements for a few months now, and my energy levels are definitely up.

But Precision Care doesn’t stop at vitamins...

Your Gut, Your Personal Diet

A company named Viome, for example, measures the composition of your personal microbiome—that means your gut bacteria—and then provides continuous dietary guidance via app.

“When the microbes in your gut are out of balance, your body can't absorb nutrients the way it should,” explains the website. “The result of this is inflammation, the root of almost every chronic disease.”

According to Viome, eating chocolate can be totally okay if you have one type of gut bacteria, but poison if you have another... and the same goes for just about any other food.

Once you find out which foods are beneficial for your individual gut flora and which you should avoid, you can lose weight quickly and easily, and stay healthy long-term.

The medical and pharmaceutical industries, too, are banking heavily on Precision Care today.

From 2014 through mid-2016, Memorial Sloan Kettering Cancer Center mapped the genomic profile of more than 10,000 tumors to help researchers develop personalized cancer therapies.

That’s a big shift from the old medical model. And it’s only now possible—thanks to advancements in areas like genomics, molecular diagnostics, and computer analytics.

For the future, the idea is to treat each patient based on his or her personal genetics, health history, lifestyle, and environment.

Precision Care Is a Big Opportunity for Investors

In 2017 alone, the FDA approved a record 16 Precision Care medicines. That’s 34% of all the drugs approved in the US that year… up from less than 10% only 10 years earlier.

What’s more, 42% of all drugs in development and 73% of all cancer drugs in development are Precision Care medicines.

Statistics portal Statista reports that in 2018, the global Precision Care market—which includes diagnostics, therapeutics, medical care, and nutrition & wellness—was valued at $1.76 trillion.

And it’s expected to grow by more than $1 trillion over the next four years. That’s more than the GDPs of all but the world’s 16 richest countries.

One of the easiest ways to profit from this mega-trend is to invest in one of the key players in this field.

Using Genetics to Make Better Medicine

GlaxoSmithKline (GSK) is a pharmaceutical giant with a market capitalization of $203.4 billion.


Source:StockCharts.com (Click to enlarge)

In July 2018, GSK made a deal with well-known genetic test and analysis company 23andMe. In their four-year collaboration, the two companies will focus on using genetics to develop precision medicines.

In return for the $300 million investment in 23andMe, GSK gets access to its huge database of genetic information from over 5 million customers. And 23andMe gets a deep-pocketed partner with vast experience in developing drugs and bringing them to market.

The two companies are now poised to change the game in drug discovery… to make it faster, better, and cheaper.

GSK has seen some ups and downs since that announcement, but I am long-term bullish on the stock. Note, though, that GSK is currently not one of the portfolio companies in my newsletter, Healthy Returns, so please do your own due diligence before you invest.

If you want monthly stock recommendations and ongoing guidance for the booming segments of Precision Care, Wellness Care, and Everywhere Care, I encourage you to try Healthy Returns at just $9.95 a month.

Chris Wood,
Editor, A Rich Life

Please note that the companies Chris mentions in A Rich Life are just meant to give you some ideas for your own research... not official investment recommendations. There’s no A Rich Life portfolio, and Chris doesn’t keep track of these companies.

Chris does provide actual stock picks—thoroughly researched and vetted, with entry and target prices, full company analysis, the whole nine yards—in his investment newsletter, Healthy ReturnsClick here to subscribe to Healthy Returns at a low monthly rate.


Chris Wood
Article Author

Chris Wood

Chris Wood heads our financial research team at Health & Wealth Research. He is also chief investment officer at RiskHedge, a premier research firm focused on profiting from disruptive trends. An accomplished stock picker, he booked 100%+ gains on 7 different stocks in 2017 alone.

Recent Articles

4 Challenges of Losing Weight as a Couple… and How to Overcome Them

Today, my colleague Dr. Mike Roizen is talking about a topic I rarely see discussed in online weight loss articles: How challenging it can be to lose weight when you’re not living alone—and how to meet those challenges head on.

Weight Loss Strategies for Aging People—the Pros and Cons

If you think it’s getting harder to fight weight gain as you’re aging, you’re right. One of the most important scientific discoveries of the 21st century is the existence of a fat-fighting organ that mysteriously disappears as we get older.

Genes May Determine Your Risk of Obesity

Since 1975, global obesity rates have almost tripled. In the United States alone, nearly 40% of the population is obese—defined as a body mass index (BMI) of 30 and above.

A Rich Life: Live Healthier, Invest Smarter

Sign up for this free letter and get Dr. Mike's report for smart patients: 25 Questions You Must Ask at the Hospital!
By entering your email you will also be opted in to receive occasional marketing messages from Health & Wealth as well as its parent company, Mauldin Economics. View Privacy Policy.